chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract은 임신 중 안전한가요?
No harmonised reproductive hazard (ECHA Annex VI) or SCCS/CIR reproductive prohibition for topical extracts of Chamomilla recutita, Lavandula angustifolia, Melissa officinalis, Rosmarinus officinalis or Salvia officinalis in cosmetic use; CIR assessments and cosmetic ingredient databases list these botanicals as acceptable 'as used' with no pregnancy-specific classification. Limited case reports (e.g., lavender oil endocrine-related case series) and some in vitro endocrine activity have been discussed in PubMed, but they do not constitute harmonised H361/H360 classifications or robust in vivo human reproductive hazard that would change the default scoring.
Related ingredients
Frequently asked questions
- chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract은 임신 중 안전한가요?
- No harmonised reproductive hazard (ECHA Annex VI) or SCCS/CIR reproductive prohibition for topical extracts of Chamomilla recutita, Lavandula angustifolia, Melissa officinalis, Rosmarinus officinalis or Salvia officinalis in cosmetic use; CIR assessments and cosmetic ingredient databases list these botanicals as acceptable 'as used' with no pregnancy-specific classification. Limited case reports (e.g., lavender oil endocrine-related case series) and some in vitro endocrine activity have been discussed in PubMed, but they do not constitute harmonised H361/H360 classifications or robust in vivo human reproductive hazard that would change the default scoring.
- chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract은 모유 수유 중 안전한가요?
- Topical cosmetic use of these plant extracts is not flagged by CIR or SCCS as contraindicated in lactation; no harmonised classification for developmental or lactation toxicity. Systemic exposure from routine topical cosmetic application is generally low and there are no authoritative recommendations to avoid these extracts during breastfeeding.
- chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract은 아기 피부에 안전한가요?
- Hazard and mechanism default to 0 based on lack of harmonised reproductive/developmental classification and CIR/SCCS acceptance for cosmetic use. Exposure is increased for infants (immature skin barrier, higher surface-area-to-weight), so exposure score is raised to 1. Note: botanical extracts can contain allergens or act as mild sensitizers (documented for some Chamomilla and Lavandula preparations in PubMed/EWG/CosIng), so consideration of formulation concentration and patch-testing for infants is prudent.
- VeriMom은 chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 chamomilla recutita flower/lavandula angustifolia flower/melissa officinalis leaf/rosmarinus officinalis leaf/salvia officinalis leaf extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.